Announcement, Our Impact, Press Release | 05.28.25 ASCO 2025: In a Defining Era for Oncology, PICI Drives Patient Impact Forward
Announcement, Partner Highlight, Press Release | 05.28.25 Lumanity to Support Translation of PICI’s Breakthrough Science with Go-to-Market Expertise
Announcement, Partner Highlight, Press Release | 04.24.25 Immunai and the Parker Institute Collaborate to Build One of the Largest Single-Cell Datasets in Cancer
Announcement, Our Impact | 04.23.25 From Discovery to Impact: PICI Network Accelerates Progress at AACR 2025
Announcement, Press Release | 04.10.25 Parker Institute Appoints Renowned Cancer Immunologist Dr. Ira Mellman as President of Research
Announcement, Press Release | 03.31.25 Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy
From Bench to Fireside | 03.12.25 From Metastatic Melanoma to Immune Engineering with Antoni Ribas, MD, PhD
From Bench to Fireside | 02.12.25 From the Front Lines to the Frontiers of Defeating Breast Cancer with Elizabeth Mittendorf, MD, PhD
Announcement, From Bench to Fireside | 01.31.25 From CAR T-Cell Therapy to the Impact of Mentorship with Carl June, MD